FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

The FDA approved a supplemental ANDA from Lannett Company to market a generic montelukast sodium product. Montelukast is used in the management of asthma and fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Montelukast Sodium (Montelukast Sodium)

Snippet

SUPPL AP for MONTELUKAST SODIUM (MONTELUKAST SODIUM)